427 related articles for article (PubMed ID: 34103329)
21. The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development.
Yu Y; Wang C; Clare S; Wang J; Lee SC; Brandt C; Burke S; Lu L; He D; Jenkins NA; Copeland NG; Dougan G; Liu P
J Exp Med; 2015 Jun; 212(6):865-74. PubMed ID: 25964371
[TBL] [Abstract][Full Text] [Related]
22. The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation.
Holmes TD; Pandey RV; Helm EY; Schlums H; Han H; Campbell TM; Drashansky TT; Chiang S; Wu CY; Tao C; Shoukier M; Tolosa E; Von Hardenberg S; Sun M; Klemann C; Marsh RA; Lau CM; Lin Y; Sun JC; Månsson R; Cichocki F; Avram D; Bryceson YT
Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33712472
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic challenge of identifying cases with recurrent t(8;14)(q24.21;q32.2) Involving
Bendig S; Stengel A; Walter W; Meggendorfer M; Baer C; Müller ML; Haferlach T; Kern W; Haferlach C
Leuk Lymphoma; 2022 Mar; 63(3):747-750. PubMed ID: 34738838
[No Abstract] [Full Text] [Related]
24. Priming of lineage-specifying genes by Bcl11b is required for lineage choice in post-selection thymocytes.
Kojo S; Tanaka H; Endo TA; Muroi S; Liu Y; Seo W; Tenno M; Kakugawa K; Naoe Y; Nair K; Moro K; Katsuragi Y; Kanai A; Inaba T; Egawa T; Venkatesh B; Minoda A; Kominami R; Taniuchi I
Nat Commun; 2017 Sep; 8(1):702. PubMed ID: 28951542
[TBL] [Abstract][Full Text] [Related]
25. Realization of the T Lineage Program Involves GATA-3 Induction of Bcl11b and Repression of Cdkn2b Expression.
Thompson PK; Chen ELY; de Pooter RF; Frelin C; Vogel WK; Lee CR; Venables T; Shah DK; Iscove NN; Leid M; Anderson MK; Zúñiga-Pflücker JC
J Immunol; 2022 Jul; 209(1):77-92. PubMed ID: 35705252
[TBL] [Abstract][Full Text] [Related]
26. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
Gutierrez A; Kentsis A; Sanda T; Holmfeldt L; Chen SC; Zhang J; Protopopov A; Chin L; Dahlberg SE; Neuberg DS; Silverman LB; Winter SS; Hunger SP; Sallan SE; Zha S; Alt FW; Downing JR; Mullighan CG; Look AT
Blood; 2011 Oct; 118(15):4169-73. PubMed ID: 21878675
[TBL] [Abstract][Full Text] [Related]
27. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells.
Lessel D; Gehbauer C; Bramswig NC; Schluth-Bolard C; Venkataramanappa S; van Gassen KLI; Hempel M; Haack TB; Baresic A; Genetti CA; Funari MFA; Lessel I; Kuhlmann L; Simon R; Liu P; Denecke J; Kuechler A; de Kruijff I; Shoukier M; Lek M; Mullen T; Lüdecke HJ; Lerario AM; Kobbe R; Krieger T; Demeer B; Lebrun M; Keren B; Nava C; Buratti J; Afenjar A; Shinawi M; Guillen Sacoto MJ; Gauthier J; Hamdan FF; Laberge AM; Campeau PM; Louie RJ; Cathey SS; Prinz I; Jorge AAL; Terhal PA; Lenhard B; Wieczorek D; Strom TM; Agrawal PB; Britsch S; Tolosa E; Kubisch C
Brain; 2018 Aug; 141(8):2299-2311. PubMed ID: 29985992
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic isoform switch of tumor suppressor BCL11B in adult T-cell leukemia/lymphoma.
Permatasari HK; Nakahata S; Ichikawa T; Fauzi YR; Kiyonari H; Shide K; Kameda T; Shimoda K; Ono M; Taki T; Taniwaki M; Futakuchi M; Morishita K
Exp Hematol; 2022 Jul; 111():41-49. PubMed ID: 35421541
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment.
Romano O; Peano C; Tagliazucchi GM; Petiti L; Poletti V; Cocchiarella F; Rizzi E; Severgnini M; Cavazza A; Rossi C; Pagliaro P; Ambrosi A; Ferrari G; Bicciato S; De Bellis G; Mavilio F; Miccio A
Sci Rep; 2016 Apr; 6():24724. PubMed ID: 27095295
[TBL] [Abstract][Full Text] [Related]
30. Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.
Huang X; Chen S; Shen Q; Chen S; Yang L; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hematology; 2011 Jul; 16(4):236-42. PubMed ID: 21756541
[TBL] [Abstract][Full Text] [Related]
31. The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.
Tracey LJ; Brooke-Bisschop T; Jansen PWTC; Campos EI; Vermeulen M; Justice MJ
Mol Cancer Res; 2019 Jul; 17(7):1468-1479. PubMed ID: 31015254
[TBL] [Abstract][Full Text] [Related]
32. Reduced level of the BCL11B protein is associated with adult T-cell leukemia/lymphoma.
Kurosawa N; Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Isobe M
PLoS One; 2013; 8(1):e55147. PubMed ID: 23383087
[TBL] [Abstract][Full Text] [Related]
33. BCL11B Drives Human Mammary Stem Cell Self-Renewal In Vitro by Inhibiting Basal Differentiation.
Miller DH; Jin DX; Sokol ES; Cabrera JR; Superville DA; Gorelov RA; Kuperwasser C; Gupta PB
Stem Cell Reports; 2018 Mar; 10(3):1131-1145. PubMed ID: 29503088
[TBL] [Abstract][Full Text] [Related]
34. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
[TBL] [Abstract][Full Text] [Related]
35. Haploinsufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development.
Kamimura K; Ohi H; Kubota T; Okazuka K; Yoshikai Y; Wakabayashi Y; Aoyagi Y; Mishima Y; Kominami R
Biochem Biophys Res Commun; 2007 Apr; 355(2):538-42. PubMed ID: 17306224
[TBL] [Abstract][Full Text] [Related]
36. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia.
He Z; Liao Z; Chen S; Li B; Yu Z; Luo G; Yang L; Zeng C; Li Y
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e259-e265. PubMed ID: 29749698
[TBL] [Abstract][Full Text] [Related]
37. HELIOS-BCL11B fusion gene involvement in a t(2;14)(q34;q32) in an adult T-cell leukemia patient.
Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Kurosawa N; Isobe M
Cancer Genet; 2012; 205(7-8):356-64. PubMed ID: 22867996
[TBL] [Abstract][Full Text] [Related]
38.
Yao X; Tan J; Lim KJ; Koh J; Ooi WF; Li Z; Huang D; Xing M; Chan YS; Qu JZ; Tay ST; Wijaya G; Lam YN; Hong JH; Lee-Lim AP; Guan P; Ng MSW; He CZ; Lin JS; Nandi T; Qamra A; Xu C; Myint SS; Davies JOJ; Goh JY; Loh G; Tan BC; Rozen SG; Yu Q; Tan IBH; Cheng CWS; Li S; Chang KTE; Tan PH; Silver DL; Lezhava A; Steger G; Hughes JR; Teh BT; Tan P
Cancer Discov; 2017 Nov; 7(11):1284-1305. PubMed ID: 28893800
[TBL] [Abstract][Full Text] [Related]
39. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
[TBL] [Abstract][Full Text] [Related]
40. Bcl11b transcription factor plays a role in the maintenance of the ameloblast-progenitors in mouse adult maxillary incisors.
Katsuragi Y; Anraku J; Nakatomi M; Ida-Yonemochi H; Obata M; Mishima Y; Sakuraba Y; Gondo Y; Kodama Y; Nishikawa A; Takagi R; Ohshima H; Kominami R
Mech Dev; 2013; 130(9-10):482-92. PubMed ID: 23727454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
